CHICAGO – Genetic medicine is the focus of two presentations at today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session Octo…
Blood Pressure, Glaucoma Links In Migraine Patients; Eye Care Goes Digital And Mobile
CHICAGO-Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today’s Scientific Program, to be presented at the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of O…
Beta Carotene And Retinitis Pigmentosa
CHICAGO-Today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene’s ability to improve vision in people with certain incurable r…
Uncategorized
iPhone images: Good enough for medical use?
Like the rest of society, medicine increasingly relies on digital systems and mobile devices to manage work flow and enhance communications. Eye M.D.s (ophthalmologists) routinely evaluate internet-transmitted images of patients’ eyes as part of diagno…
Uncategorized
Seeking Genetics-Specific Treatments for Age-Related Macular Degeneration
In the past decade ophthalmologists gained a powerful tool to control vision-damaging “wet” age-related macular degeneration (wet AMD): anti-vascular endothelial growth factor (anti-VEGF) medications. Anti-VEGF drugs halt or even reverse damage in many…
Uncategorized
Proven Arthritis Drug Shows Promise versus Dry AMD
While ophthalmologists can turn to several medications for patients with vision-threatening “wet” age-related macular degeneration (AMD), there are no effective treatments for advanced “dry” AMD, the more common form. Researchers report on a phase-two …